| Epigenetics and DNA Methylation | Lifetime | 30 | US 22 | 99.86 |
| Air Quality and Health Impacts | Lifetime | 73 | US 25 | 99.78 |
| Birth, Development, and Health | Lifetime | 69 | US 21 | 99.64 |
| Climate Change and Health Impacts | Lifetime | 37 | US 15 | 99.58 |
| Health, Environment, Cognitive Aging | Lifetime | 18 | US 7 | 99.48 |
| RNA modifications and cancer | Lifetime | 340 | US 188 | 99.22 |
| Energy and Environment Impacts | Lifetime | 74 | US 18 | 99.17 |
| Carcinogens and Genotoxicity Assessment | Lifetime | 220 | US 112 | 98.59 |
| MicroRNA in disease regulation | Lifetime | 687 | US 199 | 97.91 |
| Extracellular vesicles in disease | Lifetime | 317 | US 84 | 97.28 |
| Heavy Metal Exposure and Toxicity | Lifetime | 286 | US 106 | 98.08 |
| Effects and risks of endocrine disrupting chemicals | Lifetime | 361 | US 120 | 97.99 |
| Air Quality Monitoring and Forecasting | Lifetime | 399 | US 144 | 97.79 |
| Telomeres, Telomerase, and Senescence | Lifetime | 483 | US 209 | 93.01 |
| Health, Environment, Cognitive Aging | 2021-2025 | 1 | US 1 | 99.28 |
| Epigenetics and DNA Methylation | 2021-2025 | 9 | US 6 | 99.56 |
| Birth, Development, and Health | 2021-2025 | 32 | US 14 | 98.94 |
| Air Quality and Health Impacts | 2021-2025 | 197 | US 37 | 98.47 |
| Climate Change and Health Impacts | 2021-2025 | 138 | US 28 | 97.30 |
| Extracellular vesicles in disease | 2021-2025 | 259 | US 29 | 95.67 |
| RNA modifications and cancer | 2021-2025 | 753 | US 130 | 94.63 |
| MicroRNA in disease regulation | 2021-2025 | 651 | US 68 | 93.36 |
| Adolescent and Pediatric Healthcare | 2021-2025 | 289 | US 110 | 90.28 |
| Heavy Metal Exposure and Toxicity | 2021-2025 | 791 | US 117 | 82.02 |
| Effects and risks of endocrine disrupting chemicals | 2021-2025 | 958 | US 153 | 81.72 |
| Pregnancy and Medication Impact | 2021-2025 | 853 | US 254 | 73.69 |
| Genetics, Aging, and Longevity in Model Organisms | 2021-2025 | 763 | US 318 | 73.80 |
| Identity, Memory, and Therapy | 2021-2025 | 924 | US 296 | 25.42 |
